D-0130-2019 Class II Terminated
FDA drug recall D-0130-2019 was initiated by RXQ Compounding LLC on Sep 25, 2018 and is designated Class II. Reason for recall: Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent. The recall status is terminated (terminated Oct 18, 2022). Affected quantity: 395 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 31, 2018
- Initiation Date
- Sep 25, 2018
- Termination Date
- Oct 18, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 395 vials
Product Description
Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450
Reason for Recall
Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Distribution Pattern
U.S.A. nationwide
Code Information
Lot# 04042018:58, Exp 10/17/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0130-2019
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026